Amsterdam Molecular Therapeutics 2010 Annual Report

AMSTERDAM, The Netherlands, March 4, 2011 /PRNewswire/ -- Amsterdam Molecular Therapeutics (Euronext: AMT), a leader in the field of human gene therapy, published today its 2010 Annual Report. It is available at http://www.amtbiopharma.com/news-and-events/news

PRN NLD